Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

594 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults.
Scaggs Huang F, Bernstein DI, Slobod KS, Portner A, Takimoto T, Russell CJ, Meagher M, Jones BG, Sealy RE, Coleclough C, Branum K, Dickey M, Buschle K, McNeal M, Makowski M, Nakamura A, Hurwitz JL. Scaggs Huang F, et al. Among authors: bernstein di. Hum Vaccin Immunother. 2021 Feb 1;17(2):554-559. doi: 10.1080/21645515.2020.1779517. Epub 2020 Aug 4. Hum Vaccin Immunother. 2021. PMID: 32750273 Free PMC article.
Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults.
Bernstein DI, Schleiss MR, Berencsi K, Gonczol E, Dickey M, Khoury P, Cadoz M, Meric C, Zahradnik J, Duliege AM, Plotkin S. Bernstein DI, et al. J Infect Dis. 2002 Mar 1;185(5):686-90. doi: 10.1086/339003. Epub 2002 Feb 6. J Infect Dis. 2002. PMID: 11865427 Clinical Trial.
Safety and immunogenicity of glycoprotein D-adjuvant genital herpes vaccine.
Bernstein DI, Aoki FY, Tyring SK, Stanberry LR, St-Pierre C, Shafran SD, Leroux-Roels G, Van Herck K, Bollaerts A, Dubin G; GlaxoSmithKline Herpes Vaccine Study Group. Bernstein DI, et al. Clin Infect Dis. 2005 May 1;40(9):1271-81. doi: 10.1086/429240. Epub 2005 Mar 24. Clin Infect Dis. 2005. PMID: 15825029 Clinical Trial.
594 results